Advertisement
U.S. Markets open in 5 hrs 23 mins
S&P Futures
5,903.50 -2.50 (-0.04%) Dow Futures
43,555.00 +37.00 (+0.09%) Nasdaq Futures
20,443.00 -40.50 (-0.20%) Russell 2000 Futures
2,292.40 +1.20 (+0.05%) Crude Oil
69.75 +0.53 (+0.77%) Gold
2,744.70 +14.70 (+0.54%)
Blueprint Medicines Corporation (BPMC)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 86.00 |
| Open | 86.13 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 85.12 - 87.14 |
| 52 Week Range | 43.89 - 121.90 |
| Volume | |
| Avg. Volume | 648,940 |
| Market Cap | 5.448B |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.41 |
| Earnings Date | Oct 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 127.35 |
PR NewswireBlueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, October 30, 2024, to report its third quarter 2024 financial results and provide a corporate update.
ZacksWall Street Analysts Predict a 41.4% Upside in Blueprint Medicines (BPMC): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 41.4% in Blueprint Medicines (BPMC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.